ProShare Advisors’s Core Scientific CORZ Stock Holding History

ProShare Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Sell	41,546 -1,544	-4%	-$36.4K	﹤0.01%	786
2026 Q1	$645K	Sell	43,090 -10,984	-20%	-$187K	﹤0.01%	940
2025 Q4	$787K	Sell	54,074 -14,610	-21%	-$255K	﹤0.01%	909
2025 Q3	$1.23M	Buy	68,684 +10,535	+18%	+$155K	﹤0.01%	755
2025 Q2	$993K	Buy	58,149 +18,508	+47%	+$185K	﹤0.01%	822
2025 Q1	$287K	Sell	39,641 -11,620	-23%	-$132K	﹤0.01%	1445
2024 Q4	$720K	Buy	51,261 +17,557	+52%	+$259K	﹤0.01%	1061
2024 Q3	$400K	Buy	+33,704	New	+$349K	﹤0.01%	1274

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

ProShare Advisors's CORZ Position: Q2 2026 in Review

ProShare Advisors reduced its Core Scientific (CORZ) stake by 3.6% in Q2 2026, selling an estimated $36.4K and leaving 41,546 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #786.

ProShare Advisors first reported a position in CORZ in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.23M in Q3 2025. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

ProShare Advisors held 41,546 shares of Core Scientific worth $1.06M as of Q2 2026.
ProShare Advisors sold 1,544 Core Scientific shares in Q2 2026, an estimated $36.4K.
Core Scientific made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #786 holding.
ProShare Advisors first reported a position in Core Scientific in Q3 2024 and has held it in 8 quarters since.
ProShare Advisors's Core Scientific position peaked at $1.23M in Q3 2025.
413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.